医学
内科学
临床终点
肿瘤科
免疫疗法
癌症
肝细胞癌
免疫系统
肝癌
中性粒细胞与淋巴细胞比率
胃肠病学
临床试验
免疫学
淋巴细胞
作者
Hong Chang,Hanzhi Dong,Rui-Ning Li,Hongbo Zhu,Qi-mei Li,Hao Cui,Chengyi Hu,Chao‐Yi Huang,Jie Peng,Li Liu,Xuejing Zou,Lushan Xiao
摘要
HIPI, based on NLR and AFP level, is an effective indicator in ICI-treated patients with primary liver cancer. Our findings may help guide the selection and on-treatment strategies for immunotherapies for primary liver cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI